Cero Therapeutics Holdings, Inc (CERO) insider trading

Every open-market stock purchase and sale by Cero Therapeutics Holdings, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • No open-market insider buys on record.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent CERO insider trades

DateInsiderTradeValue
Mar 4, 2026Eric Francois (Director)Bought (not open market)—
Jan 7, 2026Christopher B Ehrlich (CEO)Bought (not open market)—
Jan 7, 2026Kristen Pierce (C-suite exec)Bought (not open market)—
Jan 7, 2026Brian G Atwood (Director)Bought (not open market)—
Jan 7, 2026Michael Byrnes (Director)Bought (not open market)—
Jan 7, 2026Kathleen Laporte (Director)Bought (not open market)—
Jan 7, 2026Andrew Albert Kucharchuk (CFO)Bought (not open market)—
Jan 7, 2026Shami Patel (Director)Bought (not open market)—
Jan 7, 2026Lindsey Rolfe (Director)Bought (not open market)—

Who's trading CERO

Get free alerts when an insider at Cero Therapeutics Holdings, Inc files a new trade →